Copyright © 2002 by the European Society of Cardiology.
Direct coronary stenting versus stenting with balloon pre-dilation: immediate and follow-up results of a multicentre, prospective, randomized study. The DISCO trial
a Cardiology Department, Hospital Universitario de la Princesa, Madrid, Spain
b Cardiology Department, Hospital General de Alicante, Spain
c Cardiology Department, Hospital Marqués de Valdecilla, Santander, Spain
d Cardiology Department, Hospital Infanta Cristina, Badajoz, Spain
e Cardiology Department, Hospital Virgen de la Salud, Toledo, Spain
f Cardiology Department, Hospital Miguel Servet, Zaragoza, Spain
g Cardiology Department, Hospital Virgen de las Nieves, Granada, Spain
h Cardiology Department, Hospital 12 de Octubre, Madrid, Spain
i Cardiology Department, Hospital Juan Canalejo, La Coruña, Spain
j Cardiology Department, Hospital de Navarra, Pamplona, Spain
revised July 10, 2001; accepted July 11, 2001
Abstract
Aims To assess the safety of direct coronary stenting, its influence on costs, duration of the procedure, radiation exposure, clinical outcome and angiographic restenosis.
Methods and Results We randomized 416 patients (446 lesions) to direct stent implant or stent implant following balloon pre-dilation. Patients >75 years old, heavily calcified lesions, bifurcations, total occlusions, left main lesions and very tortuous vessels were excluded. Direct stenting was successful in 217/224 lesions (96·8%). No single loss or embolization of the stent occurred. All stents in the group with pre-dilation were effectively deployed. The immediate post-procedure angiographic results were similar with both techniques. Fluoroscopy and procedural time were significantly lower in direct stenting (6·4±0·3 and 21±0·9min) than in pre-dilated stenting (9·1±0·4 and 27·5±1·1min) (P>0·001). Major adverse cardiac events during hospitalization were one in direct and four in pre-dilated stenting (P=0·05) but there were no significant differences at follow-ups at 1, 6 and 12 months between the two groups. Angiographic revaluation at 6 months was performed in 94% of the cases. Restenosis rate was 16·5% in direct stenting and 14·3% in pre-dilated stenting (P=ns).
Conclusions Direct stenting is as safe as pre-dilated stenting in selected coronary lesions. Acute angiographic results are similar but procedural costs, duration of the procedure and radiation exposure are lower in direct stenting. Overall success rate, mid-term clinical outcome and restenosis are similar with both techniques.
Key Words: Direct stenting, coronary stenting, restenosis, PTCA
f1 Correspondence: Luis Martínez Elbal MD Servicio de Cardiología, Hospital Universitario de la Princesa, Diego de León 62, 28006 Madrid, Spain.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. Cuisset, M. Hamilos, N. Melikian, E. Wyffels, J. Sarma, G. Sarno, E. Barbato, J. Bartunek, W. Wijns, and B. De Bruyne Direct stenting for stable angina pectoris is associated with reduced periprocedural microcirculatory injury compared with stenting after pre-dilation. J. Am. Coll. Cardiol., March 18, 2008; 51(11): 1060 - 1065. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Riche, R. Valderrama, and N. N. Henyan Thiazolidinediones and Risk of Repeat Target Vessel Revascularization Following Percutaneous Coronary Intervention: A meta-analysis Diabetes Care, February 1, 2007; 30(2): 384 - 388. [Abstract] [Full Text] [PDF] |
||||
![]() |
A K Mitra and D K Agrawal In stent restenosis: bane of the stent era. J. Clin. Pathol., March 1, 2006; 59(3): 232 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Herrmann Peri-procedural myocardial injury: 2005 update Eur. Heart J., December 1, 2005; 26(23): 2493 - 2519. [Abstract] [Full Text] [PDF] |
||||
![]() |
K D Dawkins, T Gershlick, M de Belder, A Chauhan, G Venn, P Schofield, D Smith, J Watkins, H H Gray, and Joint Working Group on Percutaneous Coronary Inter Percutaneous coronary intervention: recommendations for good practice and training Heart, December 1, 2005; 91(suppl_6): vi1 - vi27. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wijns, S. Verheye, G. Manoharan, G. S. Werner, E. Grube, B. De Bruyne, J. Koolen, C. W. Hamm, A. Medina, J. W. Bech, et al. Angiographic, intravascular ultrasound, and fractional flow reserve evaluation of direct stenting vs. conventional stenting using BeStent2 in a multicentre randomized trial Eur. Heart J., September 2, 2005; 26(18): 1852 - 1859. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Herzum, R Cosmeleata, and B Maisch Managing a complication after direct stenting: removal of a maldeployed stent with rotational atherectomy Heart, June 1, 2005; 91(6): e46 - e46. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Lansky, R. A. Costa, M. Mooney, M. G. Midei, H. K. Lui, W. Strickland, R. Mehran, M. B. Leon, M. E. Russell, S. G. Ellis, et al. Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease J. Am. Coll. Cardiol., April 19, 2005; 45(8): 1180 - 1185. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schluter, J. Schofer, A. H. Gershlick, E. Schampaert, W. Wijns, G. Breithardt, and for the E- and C-SIRIUS Investigators Direct stenting of native de novo coronary artery lesions with the sirolimus-eluting stent: A post hoc subanalysis of the pooled E- and C-SIRIUS trials J. Am. Coll. Cardiol., January 4, 2005; 45(1): 10 - 13. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Lansky, R. A. Costa, G. S. Mintz, Y. Tsuchiya, M. Midei, D. A. Cox, C. O'Shaughnessy, R. A. Applegate, L. A. Cannon, M. Mooney, et al. Non-Polymer-Based Paclitaxel-Coated Coronary Stents for the Treatment of Patients With De Novo Coronary Lesions: Angiographic Follow-Up of the DELIVER Clinical Trial Circulation, April 27, 2004; 109(16): 1948 - 1954. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Larrazet, A Dibie, F Philippe, R Palau, R Klausz, and F Laborde Factors influencing fluoroscopy time and dose-area product values during ad hoc one-vessel percutaneous coronary angioplasty Br. J. Radiol., July 1, 2003; 76(907): 473 - 477. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Barbato, J. Marco, and W. Wijns Direct stenting Eur. Heart J., March 1, 2003; 24(5): 394 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Babapulle and M. J. Eisenberg Coated Stents for the Prevention of Restenosis: Part I Circulation, November 19, 2002; 106(21): 2734 - 2740. [Full Text] [PDF] |
||||
![]() |
A. Colombo Direct stenting: safe with advantages for the patient and for the doctor (less fluoroscopy and procedural time) Eur. Heart J., April 2, 2002; 23(8): 592 - 595. [Full Text] [PDF] |
||||






